Brief: Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals
14/05/2024 14:24
May 14 (Reuters) - Scilex Holding Co SCLX.O :
* SCILEX HOLDING COMPANY ANNOUNCES FINAL COURT APPROVAL OF A
SETTLEMENT AGREEMENT WITH TAKEDA PHARMACEUTICALS TO RESOLVE THE
PARAGRAPH IV PATENT INFRINGEMENT LAWSUIT RELATING TO SCILEX’S
INTENT TO EXPAND THE LABEL FOR ITS FDA-APPROVED LIQUID
COLCHICINE PRODUCT, GLOPERBA®
Source text for Eikon: ID:nGNX3CyTf0
Further company coverage: SCLX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scilex Holding
See all newsEnters Promissory Note With Vivasor For Revolving Credit Up To $20 Million, On Aug 8
Brief: Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens To List On Biconomy Exchange As Early As June 23, 2026
Brief: O+C Private Credit Wade Defendants Dispute Complaint And Statement By Scilex Holding Company
Company Enters Binding Term Sheet With Datavault Ai - SEC Filing
Company May Offer Up To $500 Million In Securities - SEC Filing